Abstract
Reported here is the case of a 72-year-old renal transplant recipient with stenosis of the neo-ureter requiring stents, who was admitted to hospital with pyonephrosis caused by fungus balls. Fluconazole-resistant Candida sake was grown. Treatment with external drainage of the renal pelvis and intravenous and local administration of caspofungin resulted in relief of the obstruction. Eradication of the infection was achieved by surgical removal of the ureter with all stents and construction of a cysto-pyelostomy.
Similar content being viewed by others
References
Paya CV (1993) Fungal infections in solid-organ transplantation. Clin Infect Dis 16:677–688
Pappas PG, Rex JH, Sobel JD et al. (2004) Guidelines for treatment of candidiasis. Clin Infect Dis 38:161–189
Van’t Wout JW (1996) Fluconazole treatment of infections caused by non-albicans candidal species. Eur J Clin Microbiol Infect Dis 15:238–242
Denning DW (2003) Echinocandin antifungal drugs. Lancet 362:1142–1151
Sobel JD, Kauffman CA, McKinsey D et al. (2000) Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. Clin Infect Dis 30:19–24
Rex JH, Bennett JE, Sugar AM et al. (1994) A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 331:1325–1330
Phillips P, Shafran S, Garber G et al. (1997) Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group. Eur J Clin Microbiol Infect Dis 16:337–345
Wong-Beringer A, Jacobs RA, Guglielmo BJ (1998) Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin Infect Dis 27:603–618
Pfaller MA, Diekema DJ, Messer SA, Boyken L, Hollis RJ, Jones RN (2003) In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J Clin Microbiol 41:78–83
Espinel-Ingroff A (1998) Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol 36:2950–2956
Deresinski SC, Stevens DA (2003) Caspofungin. Clin Infect Dis 36:1445–1457
Mora-Duarte J, Betts R, Rotstein C, Colombo AL et al. (2002) Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 347:2020–2029
Rajendram R, Alp NJ, Mitchell AR, Bowler ICJW, Forfar JC (2005) Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement. Clin Infect Dis 40:e72–74
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arend, S.M., Kuijper, E.J., de Vaal, B.J. et al. Successful treatment of fungus balls due to fluconazole-resistant Candida sake obstructing ureter stents in a renal transplant patient. Eur J Clin Microbiol Infect Dis 25, 43–45 (2006). https://doi.org/10.1007/s10096-005-0066-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-005-0066-y